(Q64029747)

English

Bioequivalence - Duodart Against Avodart & Omnic

clinical trial

Statements

An Open-Label, Randomized, Single Dose Crossover Study to Determine the Bioequivalence of Duodart® 0.5mg/0.4mg (Capsule Formulation of Dutasteride 0.5mg and Tamsulosin Hydrochloride 0.4mg) Compared to Concomitant Dosing of Avodart® 0.5mg and Omnic® 0.4mg Commercial Capsules in Healthy Male Subjects. (English)
0 references
0 references
23 August 2012
0 references
5 December 2012
0 references
35
0 references
0 references
18 year
0 references
45 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit